Author Details

Sanford, D., University of Western Ontario, Canada

  • Vol 21, No 2 (2014) - Psychosocial Oncology
    Patient preferences for stopping tyrosine kinase inhibitors in chronic myeloid leukemia
    Abstract  PDF  HTML
  • Vol 22, No 2 (2015) - Case Report
    A case of transfusion independence in a patient with myelodysplastic syndrome using deferasirox, sustained for two years after stopping therapy
    Abstract  PDF  HTML
  • Vol 21, No 6 (2014) - Letter to the Editor
    Response to “Need to minimize bias when surveying patient attitudes to stopping cml treatment”
    Abstract  PDF  HTML